Matches in SemOpenAlex for { <https://semopenalex.org/work/W3008782002> ?p ?o ?g. }
Showing items 1 to 83 of
83
with 100 items per page.
- W3008782002 endingPage "519" @default.
- W3008782002 startingPage "515" @default.
- W3008782002 abstract "Abstract Aim To determine the clinical and biochemical variables associated with change in HbA1c in patients with type 2 diabetes who start sodium‐glucose linked transporter (SGLT) inhibitor therapy. Methods We performed a prospective cohort study (ACTRN12616000833460) of 48 adults (30 male, 18 female) with type 2 diabetes who attended a tertiary hospital diabetes clinic. Fasting serum and urine samples, collected during clinic visits prior to and at 1, 12 and 24 weeks after commencing SGLT inhibitor treatment, were analysed for HbA1c, electrolytes, urea, creatinine and glucose. Results After 12 weeks, SGLT inhibitor therapy was associated with respective median (97% CI) decreases in weight, blood pressure, HbA1c and urine albumin/creatinine ratio of 3.0 (1.7–3.4) kg, 8 (2–16)/4 (3–9) mmHg, 6 (3–14) mmol/mol and 0.69 (0.18–1.8) mg/mmol. These effects persisted to 24 weeks. Urinary frequency and genitourinary infection were common adverse effects. Baseline HbA1c and eGFR independently predicted ΔHbA1c at 12 weeks whereas only baseline HbA1c independently predicted ΔHbA1c at 24 weeks. Urinary fractional glucose excretion and change in fasting glucose 1 week after starting SGLT inhibitor did not contribute to prediction of glycaemic response. Conclusions SGLT inhibitor therapy in a hospital clinic setting was associated with clinical improvements comparable to those observed in clinical trials but with higher incidence of genitourinary side‐effects. Baseline HbA1c and eGFR, but not urine fractional glucose excretion, predicted glycaemic response." @default.
- W3008782002 created "2020-03-06" @default.
- W3008782002 creator A5013317756 @default.
- W3008782002 creator A5019658591 @default.
- W3008782002 creator A5039625310 @default.
- W3008782002 creator A5046649014 @default.
- W3008782002 creator A5051976300 @default.
- W3008782002 creator A5071725155 @default.
- W3008782002 date "2021-04-01" @default.
- W3008782002 modified "2023-10-16" @default.
- W3008782002 title "Factors that predict glycaemic response to sodium‐glucose linked transporter (SGLT) inhibitors" @default.
- W3008782002 cites W1955935325 @default.
- W3008782002 cites W2109728760 @default.
- W3008782002 cites W2146264128 @default.
- W3008782002 cites W2157405334 @default.
- W3008782002 cites W2187514862 @default.
- W3008782002 cites W2424539745 @default.
- W3008782002 cites W2597807848 @default.
- W3008782002 cites W2626446274 @default.
- W3008782002 cites W2750589886 @default.
- W3008782002 cites W2767809548 @default.
- W3008782002 cites W2784129643 @default.
- W3008782002 cites W2790439164 @default.
- W3008782002 cites W2800283810 @default.
- W3008782002 cites W2883001358 @default.
- W3008782002 cites W2884030420 @default.
- W3008782002 cites W2890857765 @default.
- W3008782002 cites W2913123058 @default.
- W3008782002 cites W2939222610 @default.
- W3008782002 doi "https://doi.org/10.1111/imj.14805" @default.
- W3008782002 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32092242" @default.
- W3008782002 hasPublicationYear "2021" @default.
- W3008782002 type Work @default.
- W3008782002 sameAs 3008782002 @default.
- W3008782002 citedByCount "0" @default.
- W3008782002 crossrefType "journal-article" @default.
- W3008782002 hasAuthorship W3008782002A5013317756 @default.
- W3008782002 hasAuthorship W3008782002A5019658591 @default.
- W3008782002 hasAuthorship W3008782002A5039625310 @default.
- W3008782002 hasAuthorship W3008782002A5046649014 @default.
- W3008782002 hasAuthorship W3008782002A5051976300 @default.
- W3008782002 hasAuthorship W3008782002A5071725155 @default.
- W3008782002 hasBestOaLocation W30087820022 @default.
- W3008782002 hasConcept C126322002 @default.
- W3008782002 hasConcept C134018914 @default.
- W3008782002 hasConcept C188816634 @default.
- W3008782002 hasConcept C2777180221 @default.
- W3008782002 hasConcept C2780026642 @default.
- W3008782002 hasConcept C2780306776 @default.
- W3008782002 hasConcept C555293320 @default.
- W3008782002 hasConcept C71924100 @default.
- W3008782002 hasConcept C90924648 @default.
- W3008782002 hasConceptScore W3008782002C126322002 @default.
- W3008782002 hasConceptScore W3008782002C134018914 @default.
- W3008782002 hasConceptScore W3008782002C188816634 @default.
- W3008782002 hasConceptScore W3008782002C2777180221 @default.
- W3008782002 hasConceptScore W3008782002C2780026642 @default.
- W3008782002 hasConceptScore W3008782002C2780306776 @default.
- W3008782002 hasConceptScore W3008782002C555293320 @default.
- W3008782002 hasConceptScore W3008782002C71924100 @default.
- W3008782002 hasConceptScore W3008782002C90924648 @default.
- W3008782002 hasIssue "4" @default.
- W3008782002 hasLocation W30087820021 @default.
- W3008782002 hasLocation W30087820022 @default.
- W3008782002 hasOpenAccess W3008782002 @default.
- W3008782002 hasPrimaryLocation W30087820021 @default.
- W3008782002 hasRelatedWork W1966504330 @default.
- W3008782002 hasRelatedWork W1966775726 @default.
- W3008782002 hasRelatedWork W1979139803 @default.
- W3008782002 hasRelatedWork W2030889776 @default.
- W3008782002 hasRelatedWork W2037631372 @default.
- W3008782002 hasRelatedWork W2040058909 @default.
- W3008782002 hasRelatedWork W2132898409 @default.
- W3008782002 hasRelatedWork W2748952813 @default.
- W3008782002 hasRelatedWork W2902838354 @default.
- W3008782002 hasRelatedWork W4249176446 @default.
- W3008782002 hasVolume "51" @default.
- W3008782002 isParatext "false" @default.
- W3008782002 isRetracted "false" @default.
- W3008782002 magId "3008782002" @default.
- W3008782002 workType "article" @default.